The funder’s website can be found HERE.
Funding Value and Duration
$150,000 for up to one (1) year.
The purpose of the National Women’s Health Research Initiative, a joint initiative between CIHR and Women and Gender Equality Canada announced as part of the 2021 federal budget, is to advance a coordinated research program that addresses under-researched and high-priority areas of women’s health. The National Women’s Health Research Initiative will help to ensure new evidence improves women’s, girls’, and gender-diverse people’s care and health outcomes.
The Initiative is composed of two funding streams:
a. one-year Biomedical Discovery Grants (OPEN now).
b. three year operating grants (to be launched later in 2023) to support two areas of women’s health: 1) translational research in healthcare diagnostics, therapeutics, and devices; and 2) healthcare implementation research to remove barriers to accessing healthcare.
For more information, please click HERE
The overarching vision of this Biomedical Discovery Grant funding opportunity is to support “high risk, high reward” research in high-priority areas of women’s health research. This funding opportunity will support basic science and/or other types of preclinical studies that have the potential to make significant advancements in women’s health. Projects are expected to involve cells, tissues, body parts, and/or biomarkers. Studies focused on female technology (Femtech) are also eligible.
This funding opportunity encourages projects in specific areas that have been chronically underfunded and under-researched. These areas include, but are not limited to:
- Diagnosis and treatment of endometriosis
- Early detection of ovarian cancer
- Early self-detection of breast cancer
- Treatment for gynecologic conditions, including fibroids, polycystic ovary syndrome and/or pelvic floor dysfunction
- Treatment for perimenopausal, menopausal and postmenopausal symptoms in cases where hormone therapy may not be suitable or desired
- Development of non-hormonal female contraceptives
- Gender-affirming hormone therapies
The specific objectives of this funding opportunity are:
- To promote Equity, Diversity and Inclusion–informed, cutting-edge, creative and outside the box research that has the potential to challenge, overturn or create new paradigms in high-priority areas of women’s health.
- To test highly innovative ideas and obtain the results necessary to catalyze new research or commercialization efforts that could subsequently be funded by larger grants.
For an application to be eligible the mandatory requirements below must be met:
- The Nominated Principal Applicant must be an independent researcher affiliated with a Canadian postsecondary institution and/or its affiliated institutions (including hospitals, research institutes and other non-profit organizations with a mandate for health research and/or knowledge mobilization) at the time of funding.
- The Nominated Principal Applicant must have their substantive role in Canada for the duration of the requested grant term.
- The Institution Paid must be authorized to administer CIHR funds before the funds can be released (see Administration of Funds).
- The NPA must have successfully completed module 1 of the sex- and gender-based analysis training modules available online through the CIHR Institute of Gender and Health and have submitted a Certificate of Completion (see How to Apply section).
- Principal Applicants must be independent researchers or knowledge users. Inclusion of one or more Principal Applicants is optional.
- Co-Applicants may be independent researchers; knowledge users; trainees; People with lived and living experience (PWLLE); or other. Inclusion of one or more Co-Applicants is optional.
- The addition of a trainee as a Co-Applicant is encouraged.
- An individual cannot submit more than one application as an NPA. If the NPA submits more than one application, CIHR will automatically withdraw the last application(s) submitted based on timestamp of submission
Potential applicants are encouraged to discuss this funding opportunity with their Faculty Research Facilitator.
|Faculty Deadline||Consult your Faculty Research Facilitator.|
|OVPRI Deadline (Approval Form and Application)||July 12, 2023|
|Submission to Sponsor||June 21, 2023 (Registration)
July 19, 2023 (Application)
Submitting Your Application
- Step 1) Submit an internal Carleton Approval Form
Submit an internal Approval Form through our central awards management database CUResearch:
For a user’s guide on submitting an Approval Form, click HERE.
- Step 2) Submit an external application to the granting agency
Submit an external application to the corresponding grant or award agency. To navigate to the funder’s website, click HERE